For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first consolidation (EOC) can be used to predict the need for subsequent MRD measurements ...

Acute lymphocytic leukemia (ALL) typically responds well ... The induction phase focuses on eliminating clinical signs and symptoms of cancer, or what’s known as complete remission.

An acute myeloid ... common types of leukemia in adults, and it usually occurs in people over the age of 40. Keep reading to learn about rashes, bruises, spots, and other symptoms of AML, as ...

Hematologists categorize leukemia into four main types: Acute lymphocytic leukemia (ALL ... patients often experience a constellation of symptoms that can be both bewildering and debilitating.

Acute Lymphocytic Leukemia, also known as ALL ... disease also quickly escalates through persistent and worsening symptoms as it infects white blood cells throughout the body.

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

Obecabtagene autoleucel (obe-cel; Aucatzyl) has been approved by the FDA to treat patients with relapsed or refractory B-cell ...

Partow Kebriaei, MD, discusses when the optimal time for transplant is in patients with acute lymphoblastic leukemia.

The agency reviewed data from the FELIX trial, in which 63 percent of patients achieved a complete remission on the cell therapy at any time point.

Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic ...